MedTrace Logo

Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor

NCT03848910 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2021-10-14

Study results available
· View outcomes & findings →

Summary

The aim of this clinical investigation is to investigate the subject´s overall preference, hearing performance and self-reported assessments with the Investigational device and its precursor Sound Processor (Comparator) after 6 weeks in subjects with conductive/mixed hearing loss or Single Sided Deafness, (SSD).

Conditions

  • Deafness; Sensoneural Single Sided
  • Conductive Hearing Loss
  • Mixed Hearing Loss

Interventions

DEVICE

Investigational device - Sound Processor

At visit 1 the subjects will complete self-reported assessments with respect to "pre-study experience" using precursor Sound Processor (comparator). At visit 1 the subjects will then receive the Investigational device (Sound Processor) which should be used during the following 6 weeks. At visit 3 the subjects will complete self-reported assessments regarding Investigational device and participate in audiology tests regarding both Sound Processors, comparator and Investigational device. The subject shall decide their preferred choice made by selection between Investigational device and the comparator.

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Robert Cowan, Prof · HEARing CRC550, Carlton, Melbourne

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-19
Primary Completion
2019-04-23
Completion
2019-04-23

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03848910 on ClinicalTrials.gov